Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.02.2020 | News item

Other adverse reaction research

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Below is a list of other recently published drug safety-related scientific literature.
  • Brown KA, et al. Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study. Clinical Infectious Diseases : 18 Feb 2020. Available from: URL: /link?doi=10.1093/cid/ciaa124
  • Dubey D, et al. Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum. Annals of Neurology : 22 Feb 2020. Available from: URL: /link?doi=10.1002/ana.25708
  • Iwakura T, et al. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study. PLOS One : 21 Feb 2020. Available from: URL: https://doi.org/10.1371/journal.pone.0229377
  • Kim JH, et al. The impact of drug interactions on adverse effects of oral oxycodone in male geriatric patients. Journal of Clinical Pharmacy and Therapeutics : 18 Feb 2020. Available from: URL: https://doi.org/10.1111/jcpt.13113
  • Morales D, et al. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies. British Journal of Clinical Pharmacology : 18 Feb 2020. Available from: URL: /link?doi=10.1111/bcp.14245
  • Nishtala PS, et al. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiology and Drug Safety : 20 Feb 2020. Available from: URL: /link?doi=10.1002/pds.4960
  • Pickering AN, et al. Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study. Journal of the American Geriatrics Society : 17 Feb 2020. Available from: URL: /link?doi=10.1111/jgs.16370
  • Rovira-Illamola M, et al. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level. International Journal of Clinical Pharmacy : 20 Feb 2020. Available from: URL: /link?doi=10.1007/s11096-020-00993-7
  • Silva Almodovar A, et al. Potentially Harmful Medication Use Among Medicare Patients with Heart Failure. American Journal of Cardiovascular Drugs : 12 Feb 2020. Available from: URL: /link?doi=10.1007/s40256-020-00396-z
  • Stabler S, et al. Serious infectious events and immunoglobulin replacement therapy in patients with autoimmune diseases receiving rituximab: a retrospective cohort study. Clinical Infectious Diseases : 18 Feb 2020. Available from: URL: /link?doi=10.1093/cid/ciaa127
  • Yla-Rautio H, et al. Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. International Journal of Clinical Pharmacy : 20 Feb 2020. Available from: URL: /link?doi=10.1007/s11096-020-00984-8
Literatur
Zurück zum Zitat , et al. Other adverse reaction research. Reactions Weekly 26 Feb 2020 , et al. Other adverse reaction research. Reactions Weekly 26 Feb 2020
Metadaten
Titel
Other adverse reaction research
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-75356-z

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Balsalazide

Case report

Doxorubicin

Case report

Ertapenem